GlassScriptPhysician profile
Bruce A Bornstein
NPI 1770581308
$1,454.59
in general payments reported to CMS, 2019-2025
21 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $96.32 · 2021: $20.21 · 2022: $195 · 2023: $565 · 2024: $193 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $283.85 | 2019-2025 | Keytruda, Lynparza |
| Boston Scientific Corporation | $187.48 | 2019-2023 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $122.28 | 2019-2023 | |
| Exelixis INC. | $106.41 | 2022-2023 | Cabometyx |
| Eisai INC. | $100.28 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $98.02 | 2019-2025 | Imfinzi |
| Astellas Pharma US INC | $70.26 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $59.75 | 2022-2023 | Imbruvica |
| Abbvie INC. | $54.57 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $50.70 | 2023 | Opdivo |
| Progenics Pharmaceuticals, INC. | $43.71 | 2024 | |
| Mirati Therapeutics, INC. | $39.86 | 2023 | Krazati |
| Accuray Incorporated | $38.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.70 | 2022 | |
| Seagen INC. | $29.96 | 2023 | Padcev |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionrt, INC. | $28.98 | 2020 | |
| Daiichi Sankyo INC. | $24.99 | 2019 | |
| Sobi, INC | $24.98 | 2024 | |
| Bioprotect Medical, INC. | $23.48 | 2025 | Bioprotect Balloon Implant System |
| Celgene Corporation | $16.72 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Bornstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.